Quantcast

Latest End Stage Renal Disease Stories

2013-11-27 23:04:03

This report studies the global dialysis products and services market over the forecast period of 2013 to 2018 - http://www.marketsandmarkets.com/Market-Reports/dialysis-market-1279.html. (PRWEB) November 27, 2013 The report “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] - Global Forecast to 2018”, analyzes...

2013-11-27 09:59:05

In the United States, African Americans have approximately twice the risk of end-stage renal disease compared to white Americans, despite a similar prevalence in earlier stages of chronic kidney disease. A large study co-authored by George Washington University (GW) researcher Dominic Raj, M.D., identifies factors that mediate differences in the progression of chronic kidney disease between black patients and white patients, as well as among black patients, in order to reduce the excess...

2013-11-17 23:01:26

RnRMarketResearch.com adds “Dialysis Market [(Hemodialysis - Machine, Dialyzer, Bloodlines, Concentrates, Services), (Peritoneal Dialysis - Cycler, Catheter, Dialysate, CCPD, CAPD, IPD), (End Users - Hospital, Independent Dialysis Center, Home Dialysis)] – Global Forecast to 2018” to its store. As of 2013, North America (comprising the U.S. and Canada) holds the largest share of the global dialysis market. Dallas, Texas (PRWEB) November 17, 2013 The global dialysis market is broadly...

2013-11-05 23:24:03

Medical factoring and finance company Alleon Capital Partners, LLC closes a $2,000,000 medical accounts receivable financing facility with Nationwide Laboratory Services, Inc. The funding will support the lab's growth initiative. Englewood, NJ (PRWEB) November 05, 2013 Alleon Capital Partners, LLC (“Alleon”), a medical factoring and financing company headquartered in Englewood N.J., announces the closing of a $2,000,000 medical accounts receivable financing facility with...

2013-09-10 23:27:21

Approval of This Novel Phosphate Binder Will Be a Major Milestone for the Company Cary, NC (PRWEB) September 10, 2013 BioLink Life Sciences, Inc., a biopharmaceutical innovator, announced today that the U.S. Food & Drug Administration (FDA) has accepted its New Drug Application for PiLo™ (calcium succinate capsules) for review. PiLo™ is the Company's patented phosphate binder for the treatment of elevated blood phosphate in patients with end stage renal disease (ESRD). Upon...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related